Micropoint BioScience Inc.

3521 Leonard Court, 95054 Santa Clara, CA
United States of America

Telephone +1 408 588-1682
Fax +1 408 588-1620

This company is co-exhibitor of
Messe Düsseldorf North America


Hall map

MEDICA 2016 hall map (Hall 3): stand D29-11

Fairground map

MEDICA 2016 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.14  Rapid tests - clinical chemistry

Rapid tests - clinical chemistry

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.14  Rapid tests - clinical chemistry
  •  Point of care - testing systems

Point of care - testing systems

Our products

Product category: Rapid tests - clinical chemistry, Point of care - testing systems

mLabs (R) BNP

Rapid Evaluation for Congestive Heart Failure

To date, echocardiography has been used to diagnose cardiovascular diseases, and it is one of the most widely used diagnostic tests for heart failure (HF). An echocardiogram is labor-intensive and thus expensive in comparison with biochemical markers such as BNP.

Micropoint’s BNP product is an in-vitro dagnostic test that offers early, rapid insight into cardiovascular function and prognosis. Using this assay clinical staff can quickly rule out congestive heart failure, can reduce unnecessary hospital admissions, costs, and length of stay, and improve clinical outcomes.

Micropoint’s BNP offers the advantages of speed, simplicity and stability. With whole blood sample testing no lab equipment is required, although plasma and serum are acceptable also. Results are stable after 8 minutes.

Clinical Applications:
Early detection, diagnosis and evaluation of severity of heart failure

More Less

About us

Company details

MicroPoint Bioscience Inc (MBI) is a leading provider of microfluidic devices and systems for medical and biomedical applications. It is dedicated to the research, development, manufacturing, and marketing of the "Lab-On-Chip"products based on the MEMS (Micro-Electro-Mechanical System) technology. It provides customized products and cost effective solutions for various clients in life science and health related applications such as medical diagnostics, environmental protection, food safety and bio-medical research.

In the medical diagnostic field, MBI's Point-Of-Care (POC) diagnostic devices and microfluidic cartridges provide fast, efficient, safe, accurate, and low-cost solutions for the early diagnosis and monitoring of cardiovascular   diseases and   tumors. With the introduction of the innovative POC diagnostic system, mLabs TM , MBI provides the end-users a flexible common platform for the in-vitro diagnostics conducted in the emergency rooms, at the patient's bedside, and in physician's offices. mLabs TM based technologies have been patented in US, Europe and China

Founded in 2006, MicroPoint Bioscience Inc. is headquartered in Santa Clara, CA. MBI's China headquarter is located in Shenzhen, a fast growing metropolitan region neighboring Hong Kong in southern China . MBI also has a branch office in Beijing , China .

More Less

Company data



Area of business